Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for psoriasis patients who are non-responders to etanercept
2006-004971-37Phase 4Terminated
- Sponsor
- King's College London
- Start
- Feb 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in psoriasis, sponsored by King's College London. Primary endpoint: PASI 50 improvement at week 12 of adalimumab therapy. Started Feb 2007; status: terminated.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2006-004971-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004971-37.